Close Menu

New Products

Jan 23, 2019

Bio-Rad Laboratories qUAntify Advance Control

Bio-Rad Laboratories has launched the qUAntify Advance Control for urinalysis testing in clinical labs. The control is used to monitor the precision of laboratory urinalysis test procedures, and it contains human urine solution and offers 31 days of open vial stability for all analytes, including ketones at room temperature. Bio-Rad added that the Unity Interlaboratory Program and Unity QC Data Management Solutions are availabe for use with qUAntify Advance. 

Jan 22, 2019

Intermountain Healthcare Precision Genomics ICG100 Myeloid Malignancies Panel

Intermountain Healthcare Precision Genomics has announced its ICG100 Myeloid Malignancies Panel to help classify and diagnose multiple blood cancer types. The panel includes 63 genes and uses peripheral blood, bone marrow aspirate, extracted DNA, or fixed samples to detect faulty gene alterations through next-generation sequencing. According to the firm, the panel identifies variants in genes linked to several cancers, including acute myeloid leukemia, myeloid proliferative neoplasm, myeloid dysplastic syndrome, and myeloid dysplastic/myeloid proliferative overlap disorders. 

Jan 22, 2019

Thermo Fisher Scientific ImmunoCAP Specific IgE

Thermo Fisher Scientific has launched its ImmunoCAP Specific IgE blood test for Ara h6. The test is for use by medical providers to better determine which patients may be at risk for life-threatening sensitivity to the Ara h6 protein component in peanuts. The test has been cleared by the US Food and Drug Administration for in vitro diagnostic use. The ImmunoCAP line of tests include assays for cross-reactive carbohydrate determinants and profilins, allergens that are contained in various plants, pollens, and foods. 

Jan 17, 2019

XIFIN's VisualStrata

XIFIN this week launched VisualStrata, a precision medicine informatics platform that curates and visualizes diagnostic, clinical, and financial data documenting patients' journey through diagnosis and treatment to outcomes. The firm said the new platform provides healthcare professionals with deeper insights into optimal disease treatments and can help drive personalized care decisions. VisualStrata seamlessly integrates with most electronic medical record systems and electronic health record systems, as well as with other products that collect patient clinical, diagnostic, and financial data. 

It also supports organizational objectives such as clinical improvement initiatives, efficiency programs, physician engagement, and population health efforts, the health information technology firm said.

Jan 15, 2019

Roche uPath Digital Pathology Software

Roche has introduced uPath, an enterprise software system for digital pathology that replaces the previous Ventana Virtuoso software from Roche subsidiary Ventana Medical Systems. The new uPath system promises to decrease image rendering times and integrate automated image analysis functions, according to the company. In developing uPath, Roche acquired Leeds Virtual Microscope technology from the University of Leeds, U.K., and the Leeds Teaching Hospitals NHS Trust in the UK.

Jan 09, 2019


Specialty biotech firm Gemelli Biotech has launched Sclero-Smart, a blood-based test that measures levels of anti-vinculin, an autoantibody which has been found to be elevated in sclerodema patients and associated with gastrointestinal complications. The finding of the association suggests a link between sclerodema and the gut microbiome, the Los Angeles-based firm said, and could lead to new microbiome-related diagnostic tools and therapeutics for the disease. The Sclero-Smart, which uses an ELISA format measures anti-vinculin levels in patients with systemic sclerosis and sclerodema. 

Jan 08, 2019

Yourgene Sage 32 Plex

Yourgene Health has launched the Sage 32 plex test, a high-throughput noninvasive prenatal testing and analysis solution for clinical laboratories. It runs on Thermo Fisher Scientific's Ion Torrent sequencing platform and allows 32 samples to be processed in parallel. The test, which will be available internationally, has improved performance due to workflow enhancements and upgraded analysis methods. Yourgene plans to launch a CE-IVD-marked version of the library preparation kit for the Sage 32 plex workflow in the coming months. The Sage test differs from Yourgene's other NIPT, the Iona test, in that it screens for a wider range of conditions, including trisomies 21, 18, and 13; sex chromosome aneuploidies; and clinically relevant microdeletions. The analysis uses a cloud-based bioinformatics solution called Sage Link.